S. 1224 · 116th Congress

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act

Stage: Reported from committee
Sponsor: Amy Klobuchar
Introduced: 2019-04-29
Latest action: 2019-06-28 · Committee on the Judiciary. Reported by Senator Graham with an amendment in the nature of a substitute and an amendment to the title. Without written report.

Subjects

Administrative law and regulatory procedures

Health

Civil actions and liability

Licensing and registrations

Competition and antitrust

Public participation and lobbying

Business ethics

Drug safety, medical device, and laboratory regulation

Federal Trade Commission (FTC)